The Singapore Exchange's Nifty futures traded 86 points, or 0.48%, higher at 17,905.5, indicating that stock markets may have a good start on Friday. The following 10 stocks may see significant price movement today.
-
Mahindra & Mahindra:
The domestic auto giant, which is enthusiastic about green transportation, will debut the XUV 400, an electric sports utility vehicle, in the first few months of 2023.
-
HDFC Bank:
To finance company expansion, the private sector lender has raised Rs3,000 crore via bonds. Bonds were distributed by the bank to investors in a private placement.
-
Vodafone Idea:
The government will buy a stake in the heavily indebted telecom operator once its stock price reaches Rs10 or above. The board of Vodafone Idea (VIL) has offered the government a stake at par, or Rs10 per share.
-
Coal India:
Investors were informed by the state-owned coal miner that raising coal prices is still challenging in the current environment of rising inflation.
-
PNC Infratech:
The National Highways Authority of India (NHAI) and the civil construction company have inked a concession agreement for a HAM project with a bid project cost of Rs1,458 crore.
-
Tata Power:
Tata Power Renewable Energy, a utility company owned by the Tata Group, announced it would build a 100 MW solar power facility for Viraj Profile in Maharashtra.
-
Reliance Capital:
The debt-ridden Anil Ambani Group's resolution process, which ended on August 29, was examined by the Committee of Creditors (CoC).
-
Future Lifestyle Fashions:
A three-month extension for convening its annual general meeting has been granted by the Registrar of Companies, according to the cash-strapped Future group's business.
-
Reliance Power:
The board of the struggling company has given the go-ahead for a plan to issue up to Rs60 crore equity shares and/or warrants at a price of Rs15.55 per share in order to generate Rs933 crore by selling equity shares to VFSI Holdings.
-
Panacea Biotec:
The production site of the drug maker's wholly-owned branch in Baddi in Himachal Pradesh has been asked to take additional corrective measures by the USFDA; else, clearance of any pending product applications from the plant risk being withheld.
For feedback and suggestions, write to us at editorial@iifl.com
